preclinical results

White arrow on a road pointing to the rising sun
Research

Amphista's targeted glue sticks the landing in early AML test

Amphista has reported preclinical leukemia data on its protein degrader, positioning the biotech to target a 2026 start date for a phase 1 trial.
Nick Paul Taylor Dec 8, 2025 7:40am
Red pill being analyzed

Rectify drug repairs bile composition in mice with liver disease

Oct 22, 2024 7:00am
Graphic of a brain inside of a lightbulb

AC Immune sees 'landmark' potential in brain-penetrating ADC

Jul 31, 2024 10:00am
Prothena logo on window

Prothena touts early data for anti-amyloid Alzheimer's drug

Jul 26, 2021 1:19pm